Skip to main content

Market Overview

Why Urovant Sciences Stock Is Trading Higher Today

Why Urovant Sciences Stock Is Trading Higher Today

Urovant Sciences (NASDAQ: UROV) shares are trading higher on Friday after the company late Thursday announced Sumitovant Biopharma will acquire the remaining stake in the company for $16.25 per share.

Urovant Sciences is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's pipeline products include Overactive Bladder (OAB), OAB in Men with Benign Prostatic Hyperplasia (BPH), and IBS-Associated Pain.

Urovant Science shares traded up 93.78% at $16.04 on Friday during the time of publication. The stock has a 52-week high of $16.08 and a 52-week low of $6.55.


Related Articles (UROV)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at